BM

Babita Mahesh Lakhwani

Active Director Director DIN 08229615
DIN 08229615 First appointment Sep 2018 Primary industry Trading
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Babita Mahesh Lakhwani

Data last updated:

Babita Mahesh Lakhwani is a Director at Rishindia Medicines Private Limited (since 2018). The company operates in Trading.

DIN 08229615
Primary Designation Director
Industry Trading
First Appointment 19 Sep 2018
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rishindia Medicines Private Limited U51909GJ2018PTC104190
Director19 Sep 20182018Active

Board colleagues of Babita Mahesh Lakhwani

NameDINCompanyDesignation
Rahul Mahesh Lakhwani08229614Rishindia Medicines Private LimitedDirector

Directorship timeline

Open interactive timeline →
Rishindia Medicines Private Limited
Premium access

Shareholding and investment profile for Babita Mahesh Lakhwani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Babita Mahesh Lakhwani

Babita Mahesh Lakhwani currently holds 1 directorship: Rishindia Medicines Private Limited (Director, since 19 Sep 2018).

Babita Mahesh Lakhwani was first appointed on 19 Sep 2018 as Director at Rishindia Medicines Private Limited.

The current boards of Babita Mahesh Lakhwani's companies include Rahul Mahesh Lakhwani (Rishindia Medicines Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available